Brief Title
CD4 in Combination With CHOP in Treating Non-cutaneous Peripheral TCell Lymphoma
Official Title
A Multicentre Open-label Dose Escalation Tiral of Zanolimumab in Combination With CHOP Chemotherapy in Patients With CD4 Positive Non-cutaneous Peripheral T-cell Lymphoma With Nodal Involvement.
Brief Summary
Evaluation of CD4 in combination with CHO chemotherapy in subjects with nodal involvement of non cutaneous Tcell lymphoma.
Study Phase
Phase 2
Study Type
Interventional
Primary Outcome
Primary Outcome Unavailable
Condition
T-cell Lymphoma
Intervention
CHOP + CD4
Study Arms / Comparison Groups
1
Description: CHOP chemo therapy + CD4 therapy
Publications
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Recruitment Information
Recruitment Status
Biological
Estimated Enrollment
5
Start Date
May 2007
Completion Date
December 2008
Primary Completion Date
October 2008
Eligibility Criteria
Inclusion Criteria: - study is closed to enrollment Exclusion Criteria: - study is closed to enrollment
Gender
All
Ages
18 Years - N/A
Accepts Healthy Volunteers
No
Contacts
, ,
Administrative Informations
NCT ID
NCT00893516
Organization ID
GEN112
Responsible Party
Sponsor
Study Sponsor
Emergent BioSolutions
Study Sponsor
, ,
Verification Date
May 2022